<DOC>
	<DOCNO>NCT00363597</DOCNO>
	<brief_summary>The main purpose study evaluate whether intestinal permeability and/or serum zonulin concentration increase children/adolescents functional dyspepsia ( FD ) . The study also explore relationship intestinal permeability , mucosal inflammation anxiety FD patient .</brief_summary>
	<brief_title>Intestinal Permeability Children/Adolescents With Functional Dyspepsia</brief_title>
	<detailed_description>Recurrent abdominal pain common complaint among school-age child , present 15 % give time . It represent common chronic pain entity pediatric patient . The great majority patient functional gastrointestinal disorder ( FGID ) . The common FGID patient functional dyspepsia ( FD ) , define upper abdominal pain discomfort unrelieved bowel movement absence structural biochemical explanation pain . The etiology FD multifactorial , include biological factor , factor view within biopsychosocial model . Biological factor include inflammation , dysmotility increase visceral sensitivity . These biological factor influence interactive psychosocial factor anxiety , depression social interaction . This study evaluate intestinal permeability measure barrier dysfunction investigate correlation increase permeability , mucosal inflammation anxiety score provide insight etiology FD , thereby assist development selection treatment modality .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<criteria>abdominal pain least 8 week duration fulfil Rome II symptom base criterion functional dyspepsia ( patient group ) ; undergo endoscopy evaluate FD follow demonstration lack clinical response standard acid reduction therapy ( patient group ) ; , inform permission/assent previous abdominal surgery ; chronic nongastrointestinal illness require regular medical care ( e.g . diabetes mellitus , juvenile rheumatoid arthritis , cystic fibrosis , cancer ) ; history adverse reaction lactulose mannitol ; use antacids laxative within 1 week prior study ; use steroid , antihistamine antihistaminelike drug within 4 week prior study ; use aspirin prohibit within one week prior study ; use nonsteroidal antiinflammatory drug ( NSAIDs ) aspirin restrict within one week prior study discretion Study Physician ; use antibiotic include neomycin ( Mycifradin ) within 4 week prior study ; pregnancy ; current chronic history within previous 6 month gastrointestinal symptom include abdominal pain discomfort , nausea , vomit , bloating , diarrhea constipation ( healthy control group ) ; nonEnglish speaking</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>dyspepsia</keyword>
	<keyword>gastrointestinal disease</keyword>
	<keyword>indigestion</keyword>
</DOC>